Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by WORDSWORTH, B. P.
Right arrow Articles by SMITH, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WORDSWORTH, B. P.
Right arrow Articles by SMITH, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1980 British Society for Rheumatology

research-article

A DOUBLE-BLIND CROSS-OVER TRIAL OF FENOPROFEN AND PHENYLBUTAZONE IN ANKYLOSING SPONDYLITIS

B. P. WORDSWORTH1,, R. W. EBRINGER1, EVELYN COGGINS2 and SUSAN SMITH3

1Department of Rheumatology Middlesex Hospital London
2School of Physiotherapy, Middlesex Hospital London
3Lilly Industries Ltd. Basingstoke, Hampshire

Correspondence to: Requests for reprints to: Dr. B. P. Wordsworth, Department of Rheumatology, Middlesex Hospital, Arthur Stanley House, Tottenham Street, London W1P 9PG.

Fenoprofen, 600 mg, three times daily, was compared with phenylbutazone, 100 mg, three times daily, in 30 patients suffering from ankylosing spondylitis in a double-blind cross-over study. Assessments were made after an initial washout period and after each month-long treatment period. Phenylbutazone significantly improved morning stiffness, finger-to-floor distance, chest expansion, overall joint pain, spinal pain, the physician's assessment of disease activity and ESR. Only chest expansion was significantly improved by fenoprofen, and phenylbutazone was significantly better than fenoprofen in its effects on finger-to-floor distance, morning stiffness, overall joint pain, spinal pain and the physician's assessment of disease activity. Side-effects were of a minor nature apart from one patient who developed rectal bleeding on phenylbutazone which recurred on rechallenging.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.